C.Q. Pharmaceutical Holding announcement: Universal Technology Group intends to acquire 2% equity of Chongqing Medicine through free transfer of state-owned equity. After this transfer, Universal Technology Group will directly hold 24% equity of Chongqing Medicine and hold 27% equity of Chongqing Medicine through holding subsidiary China Meheco Group, and further acquire the 38.47% equity of C.Q. Pharmaceutical Holding held by Chongqing Medicine indirectly through Chongqing Medicine. The acquirer will become the indirect controlling shareholder of the listed company, and SASAC will become the actual controller of the listed company.
重药控股：通用技术集团拟取得重庆医药2%股权 国务院国资委将成为公司实际控制人
C.Q. Pharmaceutical Holding: Universal Technology Group intends to acquire 2% equity of Chongqing Medicine. State-owned Assets Supervision and Administration Commission (SASAC) will become the actual controller of the company after completion of the free-
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.